JP2013543378A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013543378A5 JP2013543378A5 JP2013530569A JP2013530569A JP2013543378A5 JP 2013543378 A5 JP2013543378 A5 JP 2013543378A5 JP 2013530569 A JP2013530569 A JP 2013530569A JP 2013530569 A JP2013530569 A JP 2013530569A JP 2013543378 A5 JP2013543378 A5 JP 2013543378A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament
- hyperalgesia
- medicament according
- polypeptide
- allodynia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 45
- 208000004454 Hyperalgesia Diseases 0.000 claims 40
- 229920001184 polypeptide Polymers 0.000 claims 20
- 102000004196 processed proteins & peptides Human genes 0.000 claims 20
- 108090000765 processed proteins & peptides Proteins 0.000 claims 20
- 208000035154 Hyperesthesia Diseases 0.000 claims 18
- 206010053552 allodynia Diseases 0.000 claims 16
- 230000037396 body weight Effects 0.000 claims 16
- 125000003275 alpha amino acid group Chemical group 0.000 claims 12
- 210000004027 cell Anatomy 0.000 claims 12
- 208000002193 Pain Diseases 0.000 claims 9
- 239000002775 capsule Substances 0.000 claims 9
- 230000002269 spontaneous effect Effects 0.000 claims 8
- 208000004983 Phantom Limb Diseases 0.000 claims 6
- 206010056238 Phantom pain Diseases 0.000 claims 6
- 238000000034 method Methods 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 210000002966 serum Anatomy 0.000 claims 4
- 230000004071 biological effect Effects 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 239000012528 membrane Substances 0.000 claims 3
- 208000004296 neuralgia Diseases 0.000 claims 3
- 208000021722 neuropathic pain Diseases 0.000 claims 3
- 230000000508 neurotrophic effect Effects 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 230000035807 sensation Effects 0.000 claims 3
- 230000003442 weekly effect Effects 0.000 claims 3
- 108091035707 Consensus sequence Proteins 0.000 claims 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 239000002243 precursor Substances 0.000 claims 2
- 235000018102 proteins Nutrition 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- 241000710929 Alphavirus Species 0.000 claims 1
- 241000701822 Bovine papillomavirus Species 0.000 claims 1
- 241000711573 Coronaviridae Species 0.000 claims 1
- 241000702421 Dependoparvovirus Species 0.000 claims 1
- 206010024453 Ligament sprain Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 102100025695 Meteorin Human genes 0.000 claims 1
- 101710204352 Meteorin Proteins 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 241000288906 Primates Species 0.000 claims 1
- 241000687919 Rodinia Species 0.000 claims 1
- 241000700584 Simplexvirus Species 0.000 claims 1
- 208000010040 Sprains and Strains Diseases 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 claims 1
- 210000001130 astrocyte Anatomy 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000005611 electricity Effects 0.000 claims 1
- 210000000604 fetal stem cell Anatomy 0.000 claims 1
- 210000002950 fibroblast Anatomy 0.000 claims 1
- 230000002518 glial effect Effects 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 238000007913 intrathecal administration Methods 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 210000001178 neural stem cell Anatomy 0.000 claims 1
- 231100000862 numbness Toxicity 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- 210000000844 retinal pigment epithelial cell Anatomy 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 238000010254 subcutaneous injection Methods 0.000 claims 1
- 239000007929 subcutaneous injection Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 238000007910 systemic administration Methods 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
- 241000701447 unidentified baculovirus Species 0.000 claims 1
- 230000004580 weight loss Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201070423 | 2010-10-01 | ||
| DKPA201070423 | 2010-10-01 | ||
| US39079110P | 2010-10-07 | 2010-10-07 | |
| US61/390,791 | 2010-10-07 | ||
| PCT/DK2011/050369 WO2012041328A1 (en) | 2010-10-01 | 2011-09-30 | Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016219822A Division JP6247734B2 (ja) | 2010-10-01 | 2016-11-10 | アロディニア、痛覚過敏、自発痛及び幻肢痛の処置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013543378A JP2013543378A (ja) | 2013-12-05 |
| JP2013543378A5 true JP2013543378A5 (enExample) | 2014-11-13 |
| JP6149226B2 JP6149226B2 (ja) | 2017-06-21 |
Family
ID=59278857
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013530569A Active JP6149226B2 (ja) | 2010-10-01 | 2011-09-30 | アロディニア、痛覚過敏、自発痛及び幻肢痛の処置 |
| JP2016219822A Active JP6247734B2 (ja) | 2010-10-01 | 2016-11-10 | アロディニア、痛覚過敏、自発痛及び幻肢痛の処置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016219822A Active JP6247734B2 (ja) | 2010-10-01 | 2016-11-10 | アロディニア、痛覚過敏、自発痛及び幻肢痛の処置 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US8404642B2 (enExample) |
| EP (1) | EP2621512B1 (enExample) |
| JP (2) | JP6149226B2 (enExample) |
| KR (1) | KR101886029B1 (enExample) |
| CN (2) | CN103269708A (enExample) |
| AU (1) | AU2011307488B2 (enExample) |
| CA (1) | CA2813013C (enExample) |
| ES (1) | ES2584068T3 (enExample) |
| WO (1) | WO2012041328A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2730710C (en) | 2008-07-24 | 2021-06-08 | Nsgene A/S | Therapeutic use of a growth factor, metrnl |
| AU2011307488B2 (en) | 2010-10-01 | 2015-08-20 | Hoba Therapeutics Aps | Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
| US9474786B2 (en) | 2011-09-05 | 2016-10-25 | Nsgene A/S | Treatment of allodynia |
| CN103685771A (zh) * | 2013-12-13 | 2014-03-26 | 苏州士丹尼信息技术有限公司 | 一种集成的信息交流系统 |
| CN107184956B (zh) * | 2016-03-14 | 2020-09-08 | 上海风劲生物医药科技有限公司 | Metrnl蛋白或基因在防治脓毒血症方面的应用 |
| WO2020163469A2 (en) * | 2019-02-08 | 2020-08-13 | BioLegend, Inc. | METHODS FOR DETECTING METEORIN-β ACTIVITY |
| CA3217602A1 (en) | 2021-05-06 | 2022-11-10 | Kenneth Petersen | Prevention and treatment of chemotherapy-induced neuropathic pain |
| JP2024546758A (ja) | 2021-12-10 | 2024-12-26 | ホバ セラピューティクス エーピーエス | 侵害受容性疼痛の治療 |
Family Cites Families (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4352883A (en) | 1979-03-28 | 1982-10-05 | Damon Corporation | Encapsulation of biological material |
| US4353888A (en) | 1980-12-23 | 1982-10-12 | Sefton Michael V | Encapsulation of live animal cells |
| US4407957A (en) | 1981-03-13 | 1983-10-04 | Damon Corporation | Reversible microencapsulation of a core material |
| US5169637A (en) | 1983-03-24 | 1992-12-08 | The Liposome Company, Inc. | Stable plurilamellar vesicles |
| CA1237671A (en) | 1983-08-01 | 1988-06-07 | Michael W. Fountain | Enhancement of pharmaceutical activity |
| US4762915A (en) | 1985-01-18 | 1988-08-09 | Liposome Technology, Inc. | Protein-liposome conjugates |
| WO1987000201A1 (en) | 1985-07-05 | 1987-01-15 | Whitehead Institute For Biomedical Research | Epithelial cells expressing foreign genetic material |
| US4883666A (en) | 1987-04-29 | 1989-11-28 | Massachusetts Institute Of Technology | Controlled drug delivery system for treatment of neural disorders |
| EP0633318A1 (en) | 1987-09-11 | 1995-01-11 | Whitehead Institute For Biomedical Research | Transduced fibroblasts and uses therefor |
| US4892538A (en) | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
| US5283187A (en) | 1987-11-17 | 1994-02-01 | Brown University Research Foundation | Cell culture-containing tubular capsule produced by co-extrusion |
| US5158881A (en) | 1987-11-17 | 1992-10-27 | Brown University Research Foundation | Method and system for encapsulating cells in a tubular extrudate in separate cell compartments |
| US5106627A (en) | 1987-11-17 | 1992-04-21 | Brown University Research Foundation | Neurological therapy devices |
| US5156844A (en) | 1987-11-17 | 1992-10-20 | Brown University Research Foundation | Neurological therapy system |
| DE3829766A1 (de) | 1988-09-01 | 1990-03-22 | Akzo Gmbh | Verfahren zur herstellung von membranen |
| DE3829752A1 (de) | 1988-09-01 | 1990-03-22 | Akzo Gmbh | Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration |
| US5082670A (en) | 1988-12-15 | 1992-01-21 | The Regents Of The University Of California | Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system |
| US5185154A (en) | 1989-02-02 | 1993-02-09 | Liposome Technology, Inc. | Method for instant preparation of a drug containing large unilamellar vesicles |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US5084350A (en) | 1990-02-16 | 1992-01-28 | The Royal Institution For The Advance Of Learning (Mcgill University) | Method for encapsulating biologically active material including cells |
| US5618531A (en) | 1990-10-19 | 1997-04-08 | New York University | Method for increasing the viability of cells which are administered to the brain or spinal cord |
| US5219990A (en) | 1991-01-28 | 1993-06-15 | Biogen, Inc. | Papillomavirus e2 trans-activation repressors |
| DK0585368T3 (da) | 1991-04-25 | 1998-03-16 | Univ Brown Res Found | Implanterbart biokompatibelt immunisolatorisk vehikel til afgivelse af udvalgte terapeutiske produkter |
| WO1993022437A1 (en) | 1992-04-30 | 1993-11-11 | N.V. Innogenetics S.A. | New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology |
| ES2151541T3 (es) | 1992-12-02 | 2001-01-01 | Alkermes Inc | Microesferas que contienen hormona del crecimiento de liberacion prolongada. |
| US5512600A (en) | 1993-01-15 | 1996-04-30 | Massachusetts Institute Of Technology | Preparation of bonded fiber structures for cell implantation |
| EP0708670A4 (en) | 1993-06-23 | 1998-07-01 | Cytotherapeutics Inc | METHOD AND APPARATUS FOR HERMETICALLY CLOSING IMPLANTABLE MEMBRANE ENCAPSULATING DEVICES |
| CA2169292C (en) | 1993-08-12 | 2010-11-23 | E. Edward Baetge | Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| WO1995024929A2 (en) | 1994-03-15 | 1995-09-21 | Brown University Research Foundation | Polymeric gene delivery system |
| US5550050A (en) | 1994-04-15 | 1996-08-27 | Cytotherapeutics, Inc. | Method for implanting encapsulated cells in a host |
| US5656465A (en) | 1994-05-04 | 1997-08-12 | Therion Biologics Corporation | Methods of in vivo gene delivery |
| BR9509201A (pt) | 1994-09-09 | 1997-12-30 | Takeda Chemical Industries Ltd | Preparação de liberação sustemtada uso de um sal de metal polivalente insolúvel em água ou ligeiramente solúvel em água e processo para produzir uma preparação de liberação sustentada |
| EP0831787B1 (en) | 1995-06-07 | 2001-08-22 | Alkermes Controlled Therapeutics, Inc. | Composition for sustained release of human growth hormone |
| US5677158A (en) | 1995-06-07 | 1997-10-14 | Research Foundation Of State University Of New York | In vitro packaging of adeno-associated virus DNA |
| ZA965368B (en) | 1995-07-14 | 1997-01-14 | Novo Nordisk As | A pharmaceutical formulation |
| US5904144A (en) | 1996-03-22 | 1999-05-18 | Cytotherapeutics, Inc. | Method for treating ophthalmic diseases |
| US6027721A (en) | 1996-05-20 | 2000-02-22 | Cytotherapeutics, Inc. | Device and method for encapsulated gene therapy |
| US6054142A (en) | 1996-08-01 | 2000-04-25 | Cyto Therapeutics, Inc. | Biocompatible devices with foam scaffolds |
| US6303136B1 (en) | 1998-04-13 | 2001-10-16 | Neurotech S.A. | Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane |
| US6683058B1 (en) | 1998-04-15 | 2004-01-27 | Regents Of The University Of California | Methods for therapy of neurodegenerative disease of the brain |
| ES2326893T3 (es) | 1998-05-27 | 2009-10-21 | Genzyme Corporation | Vectores aav para la fabricacion de medicamentos para administracion potenciada por conveccion. |
| US20020055467A1 (en) * | 1998-07-06 | 2002-05-09 | Johansen Teit E. | Novel neurotrophic factors |
| US6361771B1 (en) | 1999-04-06 | 2002-03-26 | Neurotech S.A. | ARPE-19 as a platform cell line for encapsulated cell-based delivery |
| WO2001025427A1 (fr) | 1999-10-01 | 2001-04-12 | Kyowa Hakko Kogyo Co., Ltd. | Adn reagissant a la contrainte de cisaillement |
| AU1395801A (en) | 1999-11-30 | 2001-06-12 | Innogenetics N.V. | New uses of suppressive macrophage activation factors |
| CA2395676A1 (en) | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
| WO2001055343A1 (en) | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
| CA2399776A1 (en) | 2000-02-03 | 2001-08-09 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| CA2403901A1 (en) | 2000-05-02 | 2001-11-08 | Human Genome Sciences, Inc. | 29 human secreted proteins |
| US20020037281A1 (en) | 2000-05-26 | 2002-03-28 | Davidson Beverly L. | Methods of transducing neural cells using lentivirus vectors |
| US6555674B2 (en) | 2000-08-09 | 2003-04-29 | Nsgene A/S | JeT promoter |
| NZ529126A (en) | 2001-03-28 | 2010-07-30 | Biogen Idec Inc | Use of neublastin polypeptides for treating allodynia, hyperalgesic pain and phantom pain |
| AU2002364968A1 (en) | 2001-12-21 | 2003-09-02 | Diadexus, Inc. | Compositions and methods relating to hepatic specific genes and proteins |
| WO2004035732A2 (en) | 2002-08-29 | 2004-04-29 | Five Prime Therapeutics, Inc. | Human polypeptides encoded by polynucleotides and methods of their use |
| US20050203142A1 (en) * | 2002-10-24 | 2005-09-15 | Zeldis Jerome B. | Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain |
| US20050208500A1 (en) | 2003-03-04 | 2005-09-22 | Erlander Mark G | Signatures of ER status in breast cancer |
| JP4939397B2 (ja) | 2004-03-30 | 2012-05-23 | イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュ ユニバーシティ オブ エルサレム | アレルギー性反応に関与する細胞を標的化するための二重特異性抗体、ならびにその組成物および使用 |
| AU2005229434B2 (en) * | 2004-03-30 | 2010-09-30 | Nsgene A/S | Therapeutic use of a growth factor, NsG33 |
| US20070161696A1 (en) * | 2004-04-23 | 2007-07-12 | Zeldis Jerome B | Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain |
| WO2006110593A2 (en) * | 2005-04-07 | 2006-10-19 | Macrogenics, Inc. | Biological targets for the diagnosis, treatment and prevention of cancer |
| WO2006122549A2 (en) | 2005-05-17 | 2006-11-23 | Nsgene A/S | An implantable therapy system comprising a gripping element |
| JP2009513584A (ja) | 2005-10-28 | 2009-04-02 | エヌエスゲーネ・アクティーゼルスカブ | Ｇｄｎｆの送達のための移植可能な生体適合性免疫隔離ビヒクル |
| CA2643260A1 (en) | 2006-02-24 | 2007-09-07 | Neopharm, Inc. | Method and process for preparing cardiolipin |
| TWI501774B (zh) * | 2006-02-27 | 2015-10-01 | Biogen Idec Inc | 神經性病症之治療 |
| EP2152292A4 (en) * | 2007-05-02 | 2011-04-27 | Snu R&Db Foundation | ANGIOGENESIS HEMMER WITH METEORIN AS AN ACTIVE SUBSTANCE |
| KR100823156B1 (ko) * | 2007-05-02 | 2008-04-22 | 재단법인서울대학교산학협력재단 | 메테오린을 유효성분으로 포함하는 혈관신생 억제제 |
| WO2009069764A1 (ja) * | 2007-11-30 | 2009-06-04 | National University Corporation Chiba University | オピオイド鎮痛剤 |
| CA2730710C (en) * | 2008-07-24 | 2021-06-08 | Nsgene A/S | Therapeutic use of a growth factor, metrnl |
| JP5937353B2 (ja) * | 2008-08-19 | 2016-06-22 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプＪａｎｓｓｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａ Ｎａａｍｌｏｚｅ Ｖｅｎｎｏｏｔｓｃｈａｐ | 冷感−メントール受容体拮抗剤 |
| AU2009288088B2 (en) * | 2008-09-03 | 2014-12-04 | Nono Inc. | Agents and methods for treatment of pain |
| TW201031650A (en) * | 2008-12-02 | 2010-09-01 | Organon Nv | 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione |
| AU2011307488B2 (en) | 2010-10-01 | 2015-08-20 | Hoba Therapeutics Aps | Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
-
2011
- 2011-09-30 AU AU2011307488A patent/AU2011307488B2/en active Active
- 2011-09-30 ES ES11773666.0T patent/ES2584068T3/es active Active
- 2011-09-30 CN CN2011800580444A patent/CN103269708A/zh active Pending
- 2011-09-30 KR KR1020137011264A patent/KR101886029B1/ko active Active
- 2011-09-30 JP JP2013530569A patent/JP6149226B2/ja active Active
- 2011-09-30 WO PCT/DK2011/050369 patent/WO2012041328A1/en not_active Ceased
- 2011-09-30 CN CN201810021543.XA patent/CN108079279B/zh active Active
- 2011-09-30 CA CA2813013A patent/CA2813013C/en active Active
- 2011-09-30 EP EP11773666.0A patent/EP2621512B1/en active Active
- 2011-10-03 US US13/251,630 patent/US8404642B2/en active Active
-
2013
- 2013-03-14 US US13/828,362 patent/US8815810B2/en active Active
-
2014
- 2014-08-22 US US14/466,047 patent/US9314502B2/en active Active
-
2016
- 2016-11-10 JP JP2016219822A patent/JP6247734B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013543378A5 (enExample) | ||
| RU2593960C2 (ru) | Фармацевтическая композиция для лечения метаболического синдрома | |
| EP1993589B1 (en) | Treatments for neurological disorders | |
| JP2014526441A5 (enExample) | ||
| JP6403062B2 (ja) | 組織修復活性組成物及びその利用 | |
| EP2999499B1 (en) | Extended release of neuregulin for treating heart failure | |
| Jayakrishnapillai et al. | Current trend in drug delivery considerations for subcutaneous insulin depots to treat diabetes | |
| AU2010336475A1 (en) | Compositions and methods for the treatment of angiogenesis-related eye diseases | |
| EP1846022B1 (en) | Methods for treating adhesive capsulitis | |
| CN103372199A (zh) | 一种预防和治疗神经退行性疾病的新型脑部靶向制剂 | |
| JP2014529408A5 (enExample) | ||
| AU2016213899A1 (en) | Compositions and methods for treatment during non-acute periods following cns neurological injury | |
| De Galan et al. | Efficacy and safety of inhaled insulin in the treatment of diabetes mellitus | |
| US20070154534A1 (en) | Use of secretin in the treatment of schizophrenia | |
| EP3402505B1 (en) | Pharmaceutical formulations for the treatment of diabetes | |
| CN110038114B (zh) | 一种多肽在制备预防或治疗代谢综合征药物中的用途 | |
| US10160791B2 (en) | Protamine in treatment of neuronal injuries | |
| CN113956334B (zh) | 一种棕色脂肪细胞分泌肽及其衍生物在肥胖防治中的应用 | |
| CN114126636B (zh) | 用于治疗胰岛素缺乏病症的组合物 | |
| US8895505B2 (en) | Method of treatment of type 2 diabetes | |
| CN111249300B (zh) | 褪黑素联合甲钴胺在治疗糖尿病创面愈合障碍中的应用 | |
| JP2004508419A (ja) | 心電図のｑｔ間隔の短縮 | |
| AU2014271188A1 (en) | Treatment of neurological and other disorders | |
| CN115414468B (zh) | 一种趋化素样因子1衍生肽在制备镇痛制剂中的应用 | |
| CN112023027B (zh) | 胸腺素或其衍生物的应用和治疗快感缺乏型抑郁症的药物 |